US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about CSE:INNO

Recent news which mentions CSE:INNO

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Tickers AMZN CBD INNO INNO
Tags Benzinga CSE:INNO News
From Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
Tickers INNO INNO INNPF NEWS
Tags Market News FDA News
From Benzinga
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Tickers CBD INNO INNO INNPF
Tags Benzinga BI Sky Global Iris Bincovich
From Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
Tickers CBD INNO INNO INNPF
Tags Cannabis Chezy Barenholz Benzinga
From Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
Tickers CFO EEX INNO INNO
Tags Cannabis CFO News
From Benzinga